Izotropic (FRA:1R3) Beginning Cash Position: €0.14 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1R3 Izotropic Corp FRA:1R3
26 GF Score
Price €0.13
! 3 Warning Signs
View Full Analysis

What is Izotropic Beginning Cash Position?

Izotropic FRA:1R3 +1.56% 26 Beginning Cash Position is €0.14 Mil as of Jan. 2026. GuruFocus rates FRA:1R3 with a GF Score™ of 26/100. The stock has 3 warning signs investors should review.

Izotropic's Beginning Cash Position for the quarter that ended in Jan. 2026 was €0.14 Mil.

Izotropic's quarterly Beginning Cash Position declined from Jul. 2025 (€0.17 Mil) to Oct. 2025 (€0.04 Mil) but then increased from Oct. 2025 (€0.04 Mil) to Jan. 2026 (€0.14 Mil).

Izotropic's annual Beginning Cash Position declined from Apr. 2023 (€1.26 Mil) to Apr. 2024 (€0.11 Mil) and declined from Apr. 2024 (€0.11 Mil) to Apr. 2025 (€0.02 Mil).

Izotropic Beginning Cash Position Related Terms

Izotropic Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Izotropic's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Izotropic Beginning Cash Position Chart

Izotropic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only 0.41 2.98 1.26 0.11 0.02

Izotropic Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.14 0.17 0.04 0.14
FRA:1R3
26GF Score
Izotropic Corp FRA:1R3
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Izotropic Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €0.14 Mil mean?
Izotropic (FRA:1R3) has a Beginning Cash Position of €0.14 Mil as of Jan. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Izotropic and its competitors.
Is Izotropic's Beginning Cash Position too high?
Izotropic's current Beginning Cash Position is €0.14 Mil. Overall, Izotropic has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Izotropic's Beginning Cash Position compare to TMO and DHR?
Izotropic's Beginning Cash Position of €0.14 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Diagnostics & Research company?
A good Beginning Cash Position depends on the Medical Diagnostics & Research industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Izotropic and its competitors. Izotropic's current Beginning Cash Position is €0.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Izotropic stock overvalued right now?
Izotropic (FRA:1R3) has a current Beginning Cash Position of €0.14 Mil. The current Beginning Cash Position is €0.14 Mil. Izotropic's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Izotropic (FRA:1R3), the current Beginning Cash Position is €0.14 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Izotropic Business Description

Address 800 - 15355 24th Avenue, Suite 424, Surrey, BC, CAN, V4A 2H9
Izotropic Corp is a research and development company specializing in cancer research and early detection for breast cancer. It is engaged in advancing breast cancer imaging through the commercialization of medical imaging technologies. The company's current focus is on the commercialization of its first medical imaging device, IzoView, a dedicated Breast CT Imaging System, developed to provide high resolution, true 3D volumetric visualization of the breast without compression for breast cancer detection and diagnosis.
26GF Score

Get the complete analysis for FRA:1R3

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.13
Price